Financials
- Market Capitalization 9.05 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.97
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 943 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 149.50 USD | -1.32% | -1.36% | +9.20% | +98.99% | 9.67 B USD | ||
| 981 | PCVX Vaxcyte, Inc. - Common Stock | 61.16 USD | +0.11% | -1.12% | +12.22% | +44.59% | 9.10 B USD | ||
| 992 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.85 USD | +0.01% | +0.18% | +1.14% | +106.45% | 9.00 B USD | ||
| 993 | ABVX Abivax SA - American Depositary Shares | 114.30 USD | -1.91% | -2.88% | -8.49% | +39.39% | 8.98 B USD |